부산대학교 도서관

Saad J; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland.; Newman R; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland.; Khabusheva E; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland.; Aakko S; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland.; Durand E; Novartis Biomedical Research, Basel, Switzerland.; Tambe M; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland.; Kuusanmäki H; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland.; Parsons A; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland.; Miettinen JJ; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland.; Javarappa KK; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland.; JSS Academy of Higher Education and Research (JSS AHER), University Sophisticated Instrumentation Center (USIC), Mysuru, India.; Olgac EJ; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland.; Ikonen N; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland.; Kontro M; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland.; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Finland.; Foundation for the Finnish Cancer Institute, Helsinki, Finland.; Porkka K; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Finland.; Maacke H; Novartis Biomedical Research, Basel, Switzerland.; Woo J; Winship Cancer Institute of Emory University, Atlanta, GA, USA.; Halilovic E; Novartis Biomedical Research, Cambridge, MA, USA.; Heckman CA; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland.

Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE; In Process

Acs K; Oncopeptides AB, Stockholm, Sweden.; Miettinen JJ; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Sergeev P; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Heckel T; Core Unit Systems Medicine, University of Würzburg, Würzburg, Germany.; Diao Y; Oncopeptides AB, Stockholm, Sweden.; Witt-Mulder K; Oncopeptides AB, Stockholm, Sweden.; Thureson M; Oncopeptides AB, Stockholm, Sweden.; Bischler T; Core Unit Systems Medicine, University of Würzburg, Würzburg, Germany.; Huppunen ME; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Suvela M; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Obermüller J; Oncopeptides AB, Stockholm, Sweden.; ZalVac AB, Solna, Sweden.; Munawar U; Comprehensive Cancer Center Mainfranken, Würzburg, Germany.; Slipicevic A; Oncopeptides AB, Stockholm, Sweden.; One-carbon Therapeutics AB, Stockholm, Sweden.; Bargou RC; Comprehensive Cancer Center Mainfranken, Würzburg, Germany.; Lehmann F; Oncopeptides AB, Stockholm, Sweden.; Industrifonden, Stockholm, Sweden.; Gelius SS; Oncopeptides AB, Stockholm, Sweden.; Norin S; Oncopeptides AB, Stockholm, Sweden.; Schjesvold F; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway.; Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Stühmer T; Comprehensive Cancer Center Mainfranken, Würzburg, Germany.; Heckman CA; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland. caroline.heckman@helsinki.fi.

Publisher: BioMed Central Country of Publication: England NLM ID: 101590676 Publication Model: Electronic Cited Medium: Print ISSN: 2162-3619 (Print) Linking ISSN: 21623619 NLM ISO Abbreviation: Exp Hematol Oncol Subsets: PubMed not MEDLINE

Chen Y; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; He L; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Ianevski A; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Nader K; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Ruokoranta T; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; Linnavirta N; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Miettinen JJ; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Vähä-Koskela M; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Vänttinen I; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Kuusanmäki H; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; Kontro M; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; Foundation for the Finnish Cancer Institute (FCI), Helsinki, Finland.; Porkka K; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Wennerberg K; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.; Heckman CA; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Giri AK; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Foundation for the Finnish Cancer Institute (FCI), Helsinki, Finland.; Aittokallio T; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Oslo Centre for Biostatistics and Epidemiology (OCBE), University of Oslo, Oslo, Norway.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

Kaya F; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Bewicke-Copley F; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Miettinen JJ; Institute for Molecular Medicine Finland-FIMM, HiLIFE-Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Casado P; Centre for Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK.; Leddy E; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Centre for Epigenetics, Queen Mary University of London, London, E1 2AT, UK.; Deniz Ö; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Centre for Epigenetics, Queen Mary University of London, London, E1 2AT, UK.; Lavallée VP; Division of Hematology and Oncology, Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC, Canada.; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; Philippe C; INSERM U1242, University of Rennes, Rennes, France; Centre de Lutte contre le cancer Eugène Marquis, Rennes, France.; Zheng J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; University College London Hospitals NHS Foundation Trust, London, UK.; Grebien F; Department of Biological Sciences and Pathobiology, University of Veterinary Medicine, Vienna, Austria.; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.; Khan N; School of Infection, Inflammation and Immunology, University of Birmingham College of Medicine and Health, Birmingham, UK.; Krizsán S; HCEMM-SU, MTA-SE 'Lendület' Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.; Saad J; Institute for Molecular Medicine Finland-FIMM, HiLIFE-Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Nolin-Lapalme A; Institute for Research in Immunology and Cancer, Montreal, QC, Canada.; Hébert J; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Canada and Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, Canada.; Lemieux S; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Université de Montréal, Montréal, Canada.; Audemard E; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; Matthews J; Queen Mary University of London, London, UK.; Grantham M; Barts Health NHS Trust, London, UK.; Di Bella D; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Wennerberg K; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.; Parsons A; Institute for Molecular Medicine Finland-FIMM, HiLIFE-Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Gribben J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Cavenagh JD; Department of Haemato-Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.; Freeman SD; School of Infection, Inflammation and Immunology, University of Birmingham College of Medicine and Health, Birmingham, UK.; Bödör C; HCEMM-SU, MTA-SE 'Lendület' Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.; Sauvageau G; The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada.; Institute for Research in Immunology and Cancer, Montreal, QC, Canada.; Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Canada and Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, Canada.; Wang J; Centre for Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK.; Llamas-Sillero P; Experimental Hematology Lab, IIS-Fundación Jimenez Díaz, UAM, Madrid, Spain.; Cazier JB; The Francis Crick Institute, London, UK.; Taussig DC; Acute Leukaemia Team, Institute of Cancer Research, London, UK.; Bonnet D; Haematopoietic Stem Cell Lab, The Francis Crick Institute, London, UK.; Cutillas PR; Centre for Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK.; Heckman CA; Institute for Molecular Medicine Finland-FIMM, HiLIFE-Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Fitzgibbon J; Centre for Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK.; Rouault-Pierre K; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; Rio-Machin A; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. ana.rmachin@quironsalud.es.; Experimental Hematology Lab, IIS-Fundación Jimenez Díaz, UAM, Madrid, Spain. ana.rmachin@quironsalud.es.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Casado P; Cell Signalling and Proteomics Group, Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, EC1M6BQ, UK.; Rio-Machin A; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, EC1M6BQ, UK.; Miettinen JJ; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Bewicke-Copley F; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, EC1M6BQ, UK.; Rouault-Pierre K; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, EC1M6BQ, UK.; Krizsan S; HCEMM-SU Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University Budapest, Budapest, Hungary.; Parsons A; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Rajeeve V; Cell Signalling and Proteomics Group, Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, EC1M6BQ, UK.; Miraki-Moud F; Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, Sutton, UK.; Taussig DC; Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, Sutton, UK.; Bödör C; HCEMM-SU Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University Budapest, Budapest, Hungary.; Gribben J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, EC1M6BQ, UK.; Heckman C; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Fitzgibbon J; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, EC1M6BQ, UK.; Cutillas PR; Cell Signalling and Proteomics Group, Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, EC1M6BQ, UK. p.cutillas@qmul.ac.uk.; The Alan Turing Institute, The British Library, 2QR, 96 Euston Rd, London, NW1 2DB, UK. p.cutillas@qmul.ac.uk.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE

Grey W; Haematopoietic Stem Cell Laboratory, Francis Crick Institute, London NW1 1AT, UK.; York Biomedical Research Institute, Department of Biology, University of York, York YO10 5DD, UK.; Rio-Machin A; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK.; Casado P; Cell Signaling and Proteomics Group, Center for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK.; Grönroos E; Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute, London NW1 1AT, UK.; Ali S; Haematopoietic Stem Cell Laboratory, Francis Crick Institute, London NW1 1AT, UK.; Miettinen JJ; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Bewicke-Copley F; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK.; Parsons A; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Heckman CA; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Swanton C; Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute, London NW1 1AT, UK.; UCL Cancer Institute, 72 Huntley St. WC1E 6DD London, UK.; Cutillas PR; Cell Signaling and Proteomics Group, Center for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK.; Gribben J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK.; Fitzgibbon J; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK.; Bonnet D; Haematopoietic Stem Cell Laboratory, Francis Crick Institute, London NW1 1AT, UK.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Christensen, Maria H; Jensen, Søren B; Miettinen, Juho J; Luecke, Stefanie; Prabakaran, Thaneas; Reinert, Line S; Mettenleiter, Thomas; Chen, Zhijian J; Knipe, David M; Sandri‐Goldin, Rozanne M; Enquist, Lynn W; Hartmann, Rune; Mogensen, Trine H; Rice, Stephen A; Nyman, Tuula A; Matikainen, Sampsa; Paludan, Søren R

EMBO Journal. 7/1/2016, Vol. 35 Issue 13, p1385-1399. 15p.

Mirzaie M; Department of Biochemistry and Developmental Biology, University of Helsinki, Helsinki, Finland.; Gholizadeh E; Department of Biochemistry and Developmental Biology, University of Helsinki, Helsinki, Finland.; Miettinen JJ; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Ianevski F; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Ruokoranta T; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; Saarela J; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Manninen M; Orton Orthopaedic Hospital, Helsinki, Finland.; Miettinen S; Adult Stem Cell Group, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Tays Research Services, Wellbeing Services County of Pirkanmaa, Tampere University Hospital, Tampere, Finland.; Heckman CA; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland. caroline.heckman@helsinki.fi.; Jafari M; Department of Biochemistry and Developmental Biology, University of Helsinki, Helsinki, Finland. mohieddin.jafari@helsinki.fi.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101580004 Publication Model: Electronic Cited Medium: Print ISSN: 2157-9024 (Print) Linking ISSN: 21579024 NLM ISO Abbreviation: Oncogenesis Subsets: PubMed not MEDLINE

Chen Y; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; He L; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Ianevski A; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Ayuda-Durán P; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Potdar S; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Saarela J; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Miettinen JJ; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; Kytölä S; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; Miettinen S; Adult Stem Cell Group, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Research, Development and Innovation Centre, Tampere University Hospital, Tampere, Finland.; Manninen M; Orton Orthopaedic Hospital, Helsinki, Finland.; Heckman CA; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Enserink JM; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Section for Biochemistry and Molecular Biology, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.; Wennerberg K; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.; Aittokallio T; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland. tero.aittokallio@helsinki.fi.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. tero.aittokallio@helsinki.fi.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. tero.aittokallio@helsinki.fi.; Centre for Biostatistics and Epidemiology (OCBE), Faculty of Medicine, University of Oslo, Oslo, Norway. tero.aittokallio@helsinki.fi.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101284307 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1750-2799 (Electronic) Linking ISSN: 17502799 NLM ISO Abbreviation: Nat Protoc Subsets: MEDLINE

Dunphy K; Department of Biology, Maynooth University, W23 F2K8 Kildare, Ireland.; Bazou D; Department of Haematology, Mater Misericordiae University Hospital, D07 AX57 Dublin, Ireland.; Henry M; National Institute for Cellular Biotechnology, Dublin City University, D09 NR58 Dublin, Ireland.; Meleady P; National Institute for Cellular Biotechnology, Dublin City University, D09 NR58 Dublin, Ireland.; Miettinen JJ; Institute for Molecular Medicine Finland-FIMM, HiLIFE-Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, 00290 Helsinki, Finland.; Heckman CA; Institute for Molecular Medicine Finland-FIMM, HiLIFE-Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, 00290 Helsinki, Finland.; Dowling P; Department of Biology, Maynooth University, W23 F2K8 Kildare, Ireland.; O'Gorman P; Department of Haematology, Mater Misericordiae University Hospital, D07 AX57 Dublin, Ireland.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Gebraad A; Adult Stem Cell Group, Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.; Research, Development and Innovation Centre, Tampere University Hospital, 33520 Tampere, Finland.; Ohlsbom R; Adult Stem Cell Group, Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.; Research, Development and Innovation Centre, Tampere University Hospital, 33520 Tampere, Finland.; Miettinen JJ; Institute for Molecular Medicine Finland-FIMM, HiLIFE-Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, 00290 Helsinki, Finland.; Emeh P; Adult Stem Cell Group, Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.; Research, Development and Innovation Centre, Tampere University Hospital, 33520 Tampere, Finland.; Pakarinen TK; Department of Musculoskeletal Diseases, Tampere University Hospital, 33520 Tampere, Finland.; Manninen M; Orton Orthopaedic Hospital, 00280 Helsinki, Finland.; Eskelinen A; Coxa Hospital for Joint Replacement, Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.; Kuismanen K; Department of Obstetrics and Gynecology, Tampere University Hospital, 33520 Tampere, Finland.; Slipicevic A; Oncopeptides AB, 111 37 Stockholm, Sweden.; Lehmann F; Oncopeptides AB, 111 37 Stockholm, Sweden.; Nupponen NN; Oncopeptides AB, 111 37 Stockholm, Sweden.; Heckman CA; Institute for Molecular Medicine Finland-FIMM, HiLIFE-Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, 00290 Helsinki, Finland.; Miettinen S; Adult Stem Cell Group, Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.; Research, Development and Innovation Centre, Tampere University Hospital, 33520 Tampere, Finland.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE

Flanagan K; Oncopeptides AB, Stockholm, Sweden.; Kumari R; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland.; Miettinen JJ; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland.; Haney SL; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Varney ML; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Williams JT; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Majumder MM; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland.; Suvela M; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland.; Slipicevic A; Oncopeptides AB, Stockholm, Sweden.; Lehmann F; Oncopeptides AB, Stockholm, Sweden.; Nupponen NN; Oncopeptides AB, Stockholm, Sweden.; Holstein SA; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Heckman CA; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Finland.

Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

Dowling P; Department of Biology, Maynooth University, W23 F2H6 Maynooth, Ireland.; Tierney C; Department of Biology, Maynooth University, W23 F2H6 Maynooth, Ireland.; Dunphy K; Department of Biology, Maynooth University, W23 F2H6 Maynooth, Ireland.; Miettinen JJ; Institute for Molecular Medicine Finland-FIMM, HiLIFE-Helsinki Institute of Life Science, iCAN Digital Cancer Medicine Flagship, University of Helsinki, FI-00014 Helsinki, Finland.; Heckman CA; Institute for Molecular Medicine Finland-FIMM, HiLIFE-Helsinki Institute of Life Science, iCAN Digital Cancer Medicine Flagship, University of Helsinki, FI-00014 Helsinki, Finland.; Bazou D; Department of Haematology, Mater Misericordiae University Hospital, D07 KH4C Dublin, Ireland.; O'Gorman P; Department of Haematology, Mater Misericordiae University Hospital, D07 KH4C Dublin, Ireland.

Publisher: MDPI AG, Multidisciplinary Digital Publishing Institute Country of Publication: Switzerland NLM ID: 101621966 Publication Model: Electronic Cited Medium: Print ISSN: 2227-7382 (Print) Linking ISSN: 22277382 NLM ISO Abbreviation: Proteomes Subsets: PubMed not MEDLINE

Bolomsky A; Wilhelminen Cancer Research Institute, Department of Medicine I, Wilhelminenspital, Vienna, Austria.; Miettinen JJ; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Sciences (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, and.; Malyutina A; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Besse A; Department of Experimental Oncology and Hematology, Kantonsspital St Gallen, Sankt Gallen, Switzerland.; Huber J; Wilhelminen Cancer Research Institute, Department of Medicine I, Wilhelminenspital, Vienna, Austria.; Fellinger S; Wilhelminen Cancer Research Institute, Department of Medicine I, Wilhelminenspital, Vienna, Austria.; Breid H; Wilhelminen Cancer Research Institute, Department of Medicine I, Wilhelminenspital, Vienna, Austria.; Parsons A; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Sciences (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, and.; Klavins K; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.; Hannich JT; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.; Kubicek S; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.; Caers J; Department of Hematology, Centre Hospitalier Universitaire (CHU) de Liège, Liège, Belgium; and.; Hübl W; Department of Laboratory Medicine, Wilhelminenspital, Vienna, Austria.; Schreder M; Wilhelminen Cancer Research Institute, Department of Medicine I, Wilhelminenspital, Vienna, Austria.; Zojer N; Wilhelminen Cancer Research Institute, Department of Medicine I, Wilhelminenspital, Vienna, Austria.; Driessen C; Department of Experimental Oncology and Hematology, Kantonsspital St Gallen, Sankt Gallen, Switzerland.; Tang J; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Besse L; Department of Experimental Oncology and Hematology, Kantonsspital St Gallen, Sankt Gallen, Switzerland.; Heckman CA; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Sciences (HiLIFE), iCAN Digital Precision Cancer Medicine Flagship, and.; Ludwig H; Wilhelminen Cancer Research Institute, Department of Medicine I, Wilhelminenspital, Vienna, Austria.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Liu M; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Wang Y; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Miettinen JJ; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Kumari R; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Majumder MM; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Tierney C; Department of Hematology, Mater Misericordiae University Hospital, Dublin, Ireland.; Department of Biology, National University of Ireland, Maynooth, Ireland.; Bazou D; Department of Hematology, Mater Misericordiae University Hospital, Dublin, Ireland.; Parsons A; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Suvela M; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Lievonen J; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, University of Helsinki, Helsinki, Finland.; Silvennoinen R; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, University of Helsinki, Helsinki, Finland.; Anttila P; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, University of Helsinki, Helsinki, Finland.; Dowling P; Department of Biology, National University of Ireland, Maynooth, Ireland.; O'Gorman P; Department of Hematology, Mater Misericordiae University Hospital, Dublin, Ireland.; Tang J; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Heckman CA; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.

Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101630250 Publication Model: eCollection Cited Medium: Print ISSN: 2296-634X (Print) Linking ISSN: 2296634X NLM ISO Abbreviation: Front Cell Dev Biol Subsets: PubMed not MEDLINE

Miettinen JJ; Institute for Molecular Medicine Finland-FIMM, HiLIFE-Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, 00290 Helsinki, Finland.; Kumari R; Institute for Molecular Medicine Finland-FIMM, HiLIFE-Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, 00290 Helsinki, Finland.; Traustadottir GA; Stem Cell Research Unit, Biomedical Center, University of Iceland, 101 Reykjavik, Iceland.; Huppunen ME; Institute for Molecular Medicine Finland-FIMM, HiLIFE-Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, 00290 Helsinki, Finland.; Sergeev P; Institute for Molecular Medicine Finland-FIMM, HiLIFE-Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, 00290 Helsinki, Finland.; Majumder MM; Institute for Molecular Medicine Finland-FIMM, HiLIFE-Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, 00290 Helsinki, Finland.; Schepsky A; Stem Cell Research Unit, Biomedical Center, University of Iceland, 101 Reykjavik, Iceland.; Gudjonsson T; Stem Cell Research Unit, Biomedical Center, University of Iceland, 101 Reykjavik, Iceland.; Lievonen J; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland.; Bazou D; Department of Hematology, Mater Misericordiae University Hospital, D07 Dublin, Ireland.; Dowling P; Department of Biology, Maynooth University, National University of Ireland, W23 F2H6 Maynooth, Co. Kildare, Ireland.; O Gorman P; Department of Hematology, Mater Misericordiae University Hospital, D07 Dublin, Ireland.; Slipicevic A; Oncopeptides AB, 111 53 Stockholm, Sweden.; Anttila P; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland.; Silvennoinen R; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland.; Nupponen NN; Oncopeptides AB, 111 53 Stockholm, Sweden.; Lehmann F; Oncopeptides AB, 111 53 Stockholm, Sweden.; Heckman CA; Institute for Molecular Medicine Finland-FIMM, HiLIFE-Helsinki Institute of Life Science, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, 00290 Helsinki, Finland.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Välimäki E; Institute of Biotechnology, University of Helsinki, University of Helsinki, Finland.; Miettinen JJ; Lietzén N; Matikainen S; Nyman TA

Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 101125647 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-9484 (Electronic) Linking ISSN: 15359476 NLM ISO Abbreviation: Mol Cell Proteomics Subsets: MEDLINE

Miettinen JJ; Institute of Biotechnology, University of Helsinki, Helsinki, Finland.; Matikainen S; Nyman TA

Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-5514 (Electronic) Linking ISSN: 0022538X NLM ISO Abbreviation: J Virol Subsets: MEDLINE